WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration.
It’s the first abortion-related case the court has taken since a majority of the current justices struck down the constitutional right to abortion in 2022.
A group of anti-abortion doctors had asked the court to restrict access to mifepristone and to limit when in a pregnancy it could be used.
Key moments from the arguments:
Yu Darvish extends scoreless innings streak to 25 in Padres' 9
6G to be commercially available by about 2030: Experts
China's bond market issuances hit 7.16 trillion yuan in March
AI takes center stage at Beijing Film Fest
Philippines blames China for loss of giant clams in disputed shoal and urges environmental inquiry
China: Political settlement only viable way out of Ukraine crisis
China's top liquor brand reports 15.59% profit surge in Q1
WNBA franchises look to build and strengthen chemistry during camp in their hunt for championships
Company wins court ruling to continue development of Michigan factory serving EV industry
China Movie Channel relaunches premium subscription channel